‘Parentbot – A Digital healthcare Assistant (PDA)’: A mobile application-based perinatal intervention for parents: Development study
Patient Education and Counseling · 2023-09 · 114 · 107805
DOI: 10.1016/j.pec.2023.107805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Patient Education and Counseling, 2023-09. Verfasst von Joelle Yan Xin Chua und 7 weiteren Autor:innen. Beteiligte Einrichtung: Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Mobile Applications. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Ministry of Education - Singapore, National University Health System, Universitas Nasional.
Abstract (Originalsprache)
OBJECTIVE: To describe the development procedure of a mobile application-based parenting support program with integrated chatbot features entitled Parentbot - a Digital healthcare Assistant (PDA) for multi-racial Singaporean parents across the perinatal period. METHODS: The PDA development process was guided by the combined information systems research framework with design thinking modes, and Tuckman's model of team development. A user acceptability testing (UAT) process was conducted among 11 adults of child-bearing age. Feedback was obtained using a custom-made evaluation form and the 26-item User Experience Questionnaire. RESULTS: The combined information systems research framework with design thinking modes helped researchers to successfully create a PDA prototype based on end-users' needs. Results from the UAT process indicated that the PDA provided participants with an overall positive user experience. Feedback gathered from UAT participants was used to enhance the PDA. CONCLUSION: Although the effectiveness of the PDA in improving parental outcomes during the perinatal period is still being evaluated, this paper highlights the key details of developing a mobile application-based parenting intervention which future studies could learn from. PRACTICE IMPLICATIONS: Having carefully planned timelines with margins of delays, extra funds to resolve technical issues, team cohesion, and an experienced leader can facilitate intervention development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- Department of Obstetrics and Gynaecology, National University Hospital, Singapore.
- Department of Psychological Medicine, National University Hospital, Singapore.
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
- Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- School of Nursing and Midwifery Trinity College Dublin, Ireland.
Förderung
- Ministry of Education - Singapore
- National University Health System
- Universitas Nasional
Zitieren
APA
Chua, J. Y. X., Choolani, M., Chee, C. Y. I., Yi, H., Chan, Y. H., Lalor, J. G., Chong, Y. S., & Shorey, S. (2023). ‘Parentbot – A Digital healthcare Assistant (PDA)’: A mobile application-based perinatal intervention for parents: Development study. Patient Education and Counseling, 114, 107805. https://doi.org/10.1016/j.pec.2023.107805
Vancouver
Chua JYX, Choolani M, Chee CYI, Yi H, Chan YH, Lalor JG, et al. ‘Parentbot – A Digital healthcare Assistant (PDA)’: A mobile application-based perinatal intervention for parents: Development study. Patient Education and Counseling. 2023;114:107805. doi:10.1016/j.pec.2023.107805
BibTeX
@article{Chua2023,
author = {Chua, Joelle Yan Xin and Choolani, Mahesh and Chee, Cornelia Yin Ing and Yi, Huso and Chan, Yiong Huak and Lalor, Joan Gabrielle and Chong, Yap Seng and Shorey, Shefaly},
title = {‘Parentbot – A Digital healthcare Assistant (PDA)’: A mobile application-based perinatal intervention for parents: Development study},
journal = {Patient Education and Counseling},
year = {2023},
volume = {114},
pages = {107805},
doi = {10.1016/j.pec.2023.107805}
}
EUVIMED